Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment

ABSTRACT: Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment

PROVIDER: PRJNA509440 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8312130.fastq.gz	Fastqsanger.gz
	SRR8312140.fastq.gz	Fastqsanger.gz
	SRR8312131.fastq.gz	Fastqsanger.gz
	SRR8312132.fastq.gz	Fastqsanger.gz
	SRR8312133.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment

Project description:We transiently induce the Lo19S state with a dox inducible shRNa targeting PSMD2 and explore the gene expression in the presence and absence of bortezomib

2019-03-27 | GSE123638 | GEO

mRNA expression profiles of human iPSC-derived sensory neurons treated with paclitaxel, vincristine, bortezomib or cisplatin in the presence and absence of SP600125

Project description:For our investigation of the role of c-Jun in the underlying mechanisms of chemotherapy-induced peripheral neuropathy (CIPN), human iPSCs derived from patients were differentiated into sensory neurons and subsequently treated in vitro with four different chemotherapeutic drugs (paclitaxel, vincristine, bortezomib or cisplatin) in the presence and absence of small molecule inhibitor, SP600125. The transcriptomic analyses of such treated samples revealed upregulated transcription of c-Jun mRNA across the four drug types, which was reduced upon addition of SP600125. While this suggests the involvement of the JNK signalling pathway, detailed analyses of correlation coefficient revealed that a high correlation of c-Jun with neuronal injury, neuroinflammatory, metabolic and neuromodulation markers, thus identifying a central role of c-Jun in CIPN pathophysiology.

2025-10-01 | GSE305998 | GEO

Expression profile of MM.1S tumors folloiwing treatment with bortezomib

Project description:MM.1S orthotopic tumors were analyzed fro their gene expression upon tumor outgrowth. In contorl/bortezomib/elesclmol and combo treatments.

2019-03-27 | GSE123637 | GEO

Transcriptional profile comparing liver tissue in the absence/presence of LKB1 expression

Project description:The aim of this project is to determine the differential expression of genes between liver in the absence or presence of LKB1, leading to mitosis defects observed in absence of LKB1

2017-12-02 | GSE100605 | GEO

MicroRNA Expression Profile of serum exosomes from Bortezomib-resistant and Bortezomib-response patients in multiple myeloma

2016-07-31 | GSE71435 | GEO

CD4+ T cells in presence or absence of Ikaros

Project description:CD4+ T cells in presence or absence of Ikaros

| PRJNA662885 | ENA

mRNA expression profiles of human iPSC-derived sensory neurons treated with paclitaxel, vincristine, bortezomib or cisplatin in the presence and absence of SP600125

Project description:mRNA expression profiles of human iPSC-derived sensory neurons treated with paclitaxel, vincristine, bortezomib or cisplatin in the presence and absence of SP600125

| PRJNA1308861 | ENA

MicroRNA Expression Profile of serum exosomes from Bortezomib-resistant and Bortezomib-response patients in multiple myeloma

Project description:MicroRNA microarray profilling analysis was performed on exosomes derived from serum in patients with myeloma in two conditions of therapeutic efficacy, Bortezomib resistance and Bortezomib response. Bortezomib is approved and widely used treating myeloma. Two kinds of sample were analyzed. MicroRNA microarray profilling analysis (using miRCURY LNA microRNA Array, 7th generation REV - hsa, mmu & rno, mirBase release 18, ProductNumber=208520,208521,208522) was performed on exosomes derived from serum in patients with myeloma in two conditions of therapeutic efficacy, Bortezomib resistance and Bortezomib response.

2016-07-31 | E-GEOD-71435 | biostudies-arrayexpress

HOXB13 expression in T47D cells in presence/absence of estradiol

Project description:HOXB13 expression in T47D cells in presence/absence of estradiol

| PRJNA1107570 | ENA

Expression profile of MM.1S tumors folloiwing treatment with bortezomib

Project description:Expression profile of MM.1S tumors folloiwing treatment with bortezomib

| PRJNA509438 | ENA